Articles From: MicroStrategy Selected as an Agile BI Platform "Leader" in Report Published by Independent Research Firm to Celsion Corporation to Hold Second Quarter 2014 Financial Results


Noted for "Leading Desktop and Cloud Agile BI Tools" in Latest Research TYSONS CORNER, Va.
Sign-up for MicroStrategy Selected as an Agile BI Platform "Leader" in Report Published by Independent Research Firm investment picks
2014/7/31
Hecla Mining Company ( NYSE:HL ) today announced a second quarter net loss applicable to common shareholders of $14.5 million, or $0.04 per share, and a loss after adjustments applicable to common shareholders of $0.8 million, or $0.00 per share.
Sign-up for Hecla Reports Second Quarter 2014 Results investment picks
COLUMBIA, Md.
Sign-up for GP Strategies Reports Record Second Quarter 2014 Financial Results investment picks
NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Sequential Brands Group, Inc. ("Sequential" or the "Company") (Nasdaq:SQBG) will issue financial results for its second quarter ended June 30, 2014 before the market opens on Thursday, August 7, 2014.
Sign-up for Sequential Brands Group to Announce Second Quarter 2014 Financial Results on August 7, 2014 investment picks
ORLANDO, Fla.
Sign-up for Darden Announces Accelerated Stock Buyback investment picks
SALT LAKE CITY, July 31, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA) , a biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices, announced today that it will release financial results for its second quarter 2014 on Thursday, August 7, 2014, at approximately 9:00 a.m. Eastern Time.
Sign-up for Amedica to Announce Financial Results for the Second Quarter of 2014 on Thursday, August 7, 2014 investment picks
2014/7/31
With access to a world-class Learning Library of games and apps, a kid-safe web experience out of the box, the latest and most powerful processor and a kid-tough design, LeapPad™3 is the best first tablet experience for children EMERYVILLE, Calif.
Sign-up for LeapFrog's Highest Performance Five-Inch Screen Children's Learning Tablet, LeapPad™3, Now Available investment picks
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors increased the quarterly cash dividend by 7% to $0.15 per share.
Sign-up for Span-America Increases Quarterly Cash Dividend by 7% to $0.15 Per Share investment picks
The Ryland Group, Inc. (NYSE: RYL) today announced results for its quarter ended June 30, 2014.
Sign-up for Ryland Reports Results for the Second Quarter of 2014 investment picks
Perficient, Inc. (NASDAQ: PRFT) (“Perficient”), a leading information technology and management consulting firm serving Global 2000® and other large enterprise customers throughout North America, today reported its financial results for the quarter ended June 30, 2014.
Sign-up for Perficient Reports Second Quarter 2014 Results investment picks
SAN DIEGO , July 31, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the second quarter 2014, on Thursday, August 7, 2014 before markets open.
Sign-up for Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast investment picks
LAS VEGAS , July 31, 2014 /PRNewswire/ - Bakken Energy Corp formerly Orofino Gold Corp.
Sign-up for Bakken Energy Corp, announces the launch of new web-site and update on the name change, new symbol and dividend to shareholders investment picks
2014/7/31
VANCOUVER , July 31, 2014 /PRNewswire/ - Norsat International Inc. ("Norsat") (TSX: NII and OTC BB: NSATF), a leading provider of innovative communication solutions that enable the transmission of data, audio and video for remote and challenging applications, today announced that it will release its second quarter results for 2014 on Thursday, August 7, 2014 .
Sign-up for Norsat 2014 Second Quarter Earnings Release and Conference Call Notice investment picks
- Convertible Debt Retired for Common Stock - ADDISON, Texas , July 31, 2014 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), today announced the retirement of the two convertible notes.
Sign-up for ULURU Inc. Eliminates Remaining Debt From The Balance Sheet investment picks
2014/7/31
VANCOUVER , July 31, 2014 /PRNewswire/ - Wildcat Silver Corporation (TSX: WS) ("Wildcat" or the "Company") is pleased to announce an updated resource for the lead/zinc/silver Sulfide Skarn Zone at its Hermosa Project and a C$2 million private placement that will fund additional drilling on the zone.
Sign-up for Wildcat Silver highlights Sulfide Skarn potential at Hermosa with updated resource and announces C$2 million private placement investment picks
2014/7/31
WINNIPEG, MB and MIINNEAPOLIS, MN, July 31, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the InvestMNt 2014 Conference in Minneapolis at 8:15 AM Central Time on Wednesday, August 6, 2014 .
Sign-up for IMRIS CEO Jay D. Miller to present at InvestMNt 2014 Conference investment picks
2014/7/31
The Board of Directors of El Paso Electric (NYSE:EE) has declared a regular quarterly cash dividend on its common stock of $0.28 per share.
Sign-up for El Paso Electric Announces Quarterly Dividend investment picks
BlackRock Kelso Capital Corporation (NASDAQ:BKCC) (“BlackRock Kelso Capital” or the “Company”, “we”, “us” or “our”) announced today that its Board of Directors has declared a quarterly distribution of $0.21 per share payable on October 3, 2014 to stockholders of record as of September 19, 2014.
Sign-up for BlackRock Kelso Capital Corporation Declares Regular Quarterly Distribution of $0.21 per Share, Announces June 30, 2014 Quarterly Financial Results investment picks
Comparator will be pentazocine, a Schedule IV opioid receptor agonist with lower abuse potential than common opioids Top-line data expected in fourth quarter of 2014 SHELTON, Conn., July 31, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA) , a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting peripheral kappa opioid receptors, today announced the initiation of a human abuse liability (HAL) trial of an intravenous formulation of its peripherally-selective kappa opioid agonist, CR845.
Sign-up for Cara Therapeutics Initiates Human Abuse Liability Trial of CR845 investment picks
2014/7/31
- Second-quarter highlights - North American onshore pro forma liquids volumes exceeded 201,000 barrels per day - Worldwide production averaged 636,000 barrels of oil equivalent (boe) per day; pro forma production averaged 550,000 boe per day - Generated earnings from continuing operations of $1.31 per diluted share/$505 million; adjusted earnings of $1.67 per share/$644 million - Operating activities provided net cash of $2.3 billion; $2.2 billion from continuing operations before changes in operating assets and liabilities - Repurchased 8.9 million shares of common stock - Company provides update on repositioning for North American onshore growth HOUSTON , July 31, 2014 /PRNewswire/ -- Apache Corporation (NYSE, Nasdaq: APA) today announced second-quarter 2014 earnings of $505 million or $1.31 per diluted common share and adjusted earnings, which exclude certain items that impact the comparability of results, of $644 million or $1.67
Sign-up for Apache reports 18 percent year-over-year pro forma North American onshore liquids growth for second-quarter 2014 investment picks
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that through a wholly owned subsidiary it has closed a $75.0 million credit facility with Los Angeles-based City National Bank (“CNB Facility”). The CNB Facility will expand ACRE’s financial flexibility since it will provide additional capital available for new investments as well as for other working capital and general corporate needs.
Sign-up for Ares Commercial Real Estate Corporation Closes New $75.0 Million Facility investment picks
Enzo Biochem, Inc. (NYSE:ENZ) announced today that Thomas C.
Sign-up for Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins Enzo Biochem’s Clinical Division investment picks
MIGDAL HA'EMEQ, Israel, July 31, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd.
Sign-up for Enzymotec Ltd. to Participate in the Canaccord Genuity 34th Annual Growth Conference investment picks
2014/7/31
URAC's new accreditation validates the quality of CVS/pharmacy's patient care WOONSOCKET, R.I. and WASHINGTON , July 31, 2014 /PRNewswire/ -- CVS/pharmacy and URAC announced today that CVS/pharmacy is the first pharmacy in the nation to earn the new Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry.
Sign-up for CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, will report its second quarter 2014 financial results on Monday, August 11, 2014 after the U.S. financial markets close.
Sign-up for NephroGenex Announces Date of Conference Call to Discuss Second Quarter 2014 Financial Results investment picks
2014/7/31
AUSTIN, Texas , July 31, 2014 /PRNewswire/ -- FieldPoint Petroleum Corporation (NYSE/MKT:FPP) today provided an update on recent activity.
Sign-up for FieldPoint Petroleum Provides Update investment picks
WUHAN CITY, China , July 31, 2014 /PRNewswire/ --
Sign-up for Kingold Jewelry Announces Change in Payout Schedule for Special Cash Dividend of US$0.08 Per Share; Schedules 2014 Second Quarter Financial Results and Conference Call investment picks
Conference Call on Thursday, August 7, 2014 LAWRENCEVILLE, N.J. , July 31, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its second quarter 2014 financial results at 11:00 a.m. EDT on Thursday, August 7, 2014 .
Sign-up for Celsion Corporation to Hold Second Quarter 2014 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MicroStrategy Selected as an Agile BI Platform "Leader" in Report Published by Independent Research Firm to Celsion Corporation to Hold Second Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices